XML 38 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Taxes
12 Months Ended
Jun. 30, 2022
Income Tax Disclosure [Abstract]  
Income Taxes
18.
Income Taxes

The Company had loss from continuing operations before provision for income taxes of $15.0 million and $6.8 million for the years ended June 30, 2022 and 2021, respectively. There was no foreign activity during these years.

The provision for income taxes includes the following:

 

 

For the years ended June 30,

 

(in thousands)

 

2022

 

 

2021

 

Current

 

$

106

 

 

$

1,608

 

Deferred

 

$

(85

)

 

$

67

 

Total

 

$

21

 

 

$

1,675

 

The Company recognized an income tax expense from continuing operations of $0.02 million and $1.7 million for the years ended June 30, 2022 and 2021, respectively. This expense consists solely of state and local income taxes. No federal income taxes were incurred for the years ended June 30, 2022 and 2021.

There were no intraperiod allocations during the year ended June 30, 2022. The Company recognized an income tax benefit with respect to discontinued operations of $0.1 million during the year ended June 30, 2021 related to intraperiod allocations.

The following table reconciles the expected corporate federal income tax expense (benefit), computed by multiplying the Company's loss before income taxes by the statutory tax rate of 21% to the total tax expense.

 

 

For the years ended June 30,

 

(in thousands)

 

2022

 

 

2021

 

Federal tax benefit at statutory rate

 

$

(3,153

)

 

$

(1,437

)

State taxes net of federal impact

 

 

(504

)

 

 

(289

)

Permanent adjustments

 

 

750

 

 

 

32

 

Change in valuation allowance

 

 

(27,527

)

 

 

(95,294

)

Provision to return true-up

 

 

159

 

 

 

(61

)

Deferred remeasurement

 

 

287

 

 

 

(249

)

Net operating loss and credit expirations

 

 

30,059

 

 

 

99,071

 

Stock compensation adjustment

 

 

(42

)

 

 

(53

)

Other

 

 

(8

)

 

 

(45

)

Total tax expense

 

$

21

 

 

$

1,675

 

The tax effect of temporary differences that give rise to significant portions of the Company's deferred tax assets and liabilities are as follows:

 

 

As of June 30,

 

(in thousands)

 

2022

 

 

2021

 

Deferred Tax Assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

190,535

 

 

$

217,216

 

Accruals and allowances not deductible for tax purposes

 

 

1,646

 

 

 

1,411

 

Acquired intangibles

 

 

13

 

 

 

-

 

Stock based compensation

 

 

603

 

 

 

621

 

Unrealized loss on investment

 

 

5,361

 

 

 

5,326

 

Lease liability

 

 

1,005

 

 

 

1,436

 

Investment in partnerships

 

 

10,464

 

 

 

11,482

 

Interest expense carryforward

 

 

560

 

 

 

-

 

Total deferred tax assets, gross

 

$

210,188

 

 

$

237,492

 

Less: valuation allowance

 

$

(207,085

)

 

$

(234,612

)

Total deferred tax assets, net

 

$

3,103

 

 

$

2,880

 

Deferred Tax Liabilities:

 

 

 

 

 

 

Right to use asset

 

$

(951

)

 

$

(1,348

)

Acquired intangibles

 

 

-

 

 

 

(207

)

Convertible debt discount

 

 

(213

)

 

 

-

 

Goodwill

 

 

(2,225

)

 

 

(1,696

)

Total deferred tax liabilities

 

$

(3,389

)

 

$

(3,251

)

 

 

 

 

 

 

 

Total deferred tax liabilities, net (indefinite-lived assets)

 

$

(286

)

 

$

(371

)

In light of the Company's history of cumulative operating losses, the Company recorded a valuation allowance for all of its federal and state deferred tax assets, as it is presently unable to conclude that it is more likely than not that the federal and state deferred tax assets in excess of deferred tax liabilities will be realized. The decrease of $27.6 million in the overall valuation allowance relates primarily to the expiration of federal tax attributes. The state deferred amounts reflected in the above table were calculated using the enacted tax rates. The Company will establish the related federal deferred tax liability for the benefit of the state deduction in conjunction with its analysis of the realizability of its state deferred tax assets. The Company has a net deferred tax liability due to indefinite-lived goodwill that is not amortizable for US GAAP purposes and forecasted future state income due to the reversal of taxable temporary differences in states where the Company has no net operating losses.

As of June 30, 2022, the Company has net operating loss (NOL) carryforwards for federal and state income tax purposes of approximately $821 million and $211 million, respectively. The federal NOL carryforwards generated prior to fiscal year 2018 will expire from 2023 through 2037. The federal NOL carryforwards generated in fiscal year 2018 or later may be carried forward indefinitely. The California NOL carryforwards of will expire from 2029 through 2037. The Massachusetts NOL carryforwards will expire from 2031 to 2038.

The following table reflects federal NOL carryforwards that will expire beginning in the fiscal year ended June 30, 2023 (in thousands):

Fiscal Year of Expiration

 

Federal NOL
carryforwards

 

2023

 

 

131,077

 

2024

 

 

60,132

 

2025

 

 

117,277

 

2026 through 2037

 

 

486,542

 

Indefinite

 

 

26,039

 

Total

 

$

821,067

 

Under Internal Revenue Code Section 382, the utilization of a corporation's NOL carryforwards is limited following a change in ownership (as defined by the Internal Revenue Code) of greater than 50% within a rolling three-year period. If it is determined that prior equity transactions limit the Company's NOL carryforwards, the annual limitation will be determined by multiplying the market value of the Company on the date of the ownership change by the federal long-term tax-exempt rate. Any amount exceeding the annual limitation may be carried forward to future years for the balance of the NOL carryforward period.

During the years ended June 30, 2022 and 2021, the total amount of gross unrecognized tax benefit activity was as follows (in thousands):

Balance as of June 30, 2020

 

$

44,380

 

Reductions for tax positions of prior years

 

 

(93

)

Lapse of statute of limitations

 

 

(8,268

)

Balance as of June 30, 2021

 

 

36,019

 

Addition for tax positions of prior years

 

 

509

 

Reductions for tax positions of prior years

 

 

(71

)

Lapse of statute of limitations

 

 

(4,127

)

Balance as of June 30, 2022

 

$

32,330

 

During the year ended June 30, 2021, the Company’s unrecognized tax benefits decreased by $3.7 million primarily due to the expiration of the Company’s historical research and development credits for which an unrecognized tax benefit had been established.

As of June 30, 2022 and 2021, the Company had approximately $32.3 million and $36.0 million, respectively, of unrecognized tax benefits. The unrecognized tax benefits, if recognized, would impact the effective tax rate by a corresponding amount without considering the impact of the valuation allowance.

The Company’s policy is to include interest and penalties related to unrecognized tax benefits in tax expense on the Company’s consolidated statements of operations. As of June 30, 2022 and 2021, no amount is accrued for interest associated with tax liabilities.

Although timing of the resolution and/or closure on the Company's unrecognized tax benefits is highly uncertain, the Company does not believe it is reasonably possible that the unrecognized tax benefits would materially change in the next 12 months.

The Company files U.S. federal and U.S. state tax returns. Because of NOL carryforwards, substantially all of the Company's tax years, from the 1995 through 2022 fiscal years, remain open to IRS examinations with the exception of the 2010 and 2009 fiscal years for which IRS examinations have been completed. Substantially all of the Company’s tax years, from the 1995 through 2022 fiscal years, remain open to state tax examination.